A detailed history of Legal & General Group PLC transactions in Mannkind Corp stock. As of the latest transaction made, Legal & General Group PLC holds 348,457 shares of MNKD stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
348,457
Previous 348,457 -0.0%
Holding current value
$2.38 Million
Previous $2.19 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $67,474 - $90,235
13,468 Added 4.02%
348,457 $2.19 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $228,415 - $306,246
56,399 Added 20.24%
334,989 $1.75 Million
Q1 2024

May 14, 2024

BUY
$3.25 - $5.27 $12,187 - $19,762
3,750 Added 1.36%
278,590 $1.26 Million
Q4 2023

Feb 15, 2024

BUY
$3.34 - $4.29 $84,669 - $108,751
25,350 Added 10.16%
274,840 $1 Million
Q3 2023

Nov 14, 2023

SELL
$3.91 - $5.45 $8,957 - $12,485
-2,291 Reduced 0.91%
249,490 $1.03 Million
Q2 2023

Aug 14, 2023

BUY
$3.72 - $4.79 $440,853 - $567,658
118,509 Added 88.92%
251,781 $1.02 Million
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $178,295 - $254,126
45,138 Added 51.22%
133,272 $546,000
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $11,234 - $19,976
3,720 Added 4.41%
88,134 $464,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $13,730 - $19,975
4,592 Added 5.75%
84,414 $261,000
Q2 2022

Aug 22, 2022

BUY
$2.67 - $4.77 $6,749 - $12,058
2,528 Added 3.27%
79,822 $304,000
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $181,911 - $256,266
46,764 Added 153.17%
77,294 $336,000
Q2 2021

Aug 12, 2021

BUY
$3.61 - $5.45 $19,782 - $29,866
5,480 Added 21.88%
30,530 $166,000
Q1 2021

May 17, 2021

SELL
$3.14 - $6.14 $3,435 - $6,717
-1,094 Reduced 4.18%
25,050 $98,000
Q3 2020

Nov 13, 2020

SELL
$1.56 - $2.08 $13,884 - $18,512
-8,900 Reduced 25.4%
26,144 $49,000
Q2 2020

Aug 14, 2020

BUY
$0.94 - $2.21 $3,787 - $8,904
4,029 Added 12.99%
35,044 $61,000
Q1 2020

May 14, 2020

SELL
$0.84 - $1.76 $8,738 - $18,309
-10,403 Reduced 25.12%
31,015 $32,000
Q4 2019

Feb 13, 2020

BUY
$1.14 - $1.49 $8,357 - $10,923
7,331 Added 21.51%
41,418 $53,000
Q2 2019

Aug 14, 2019

BUY
$1.09 - $1.88 $7,785 - $13,428
7,143 Added 26.51%
34,087 $39,000
Q1 2019

May 15, 2019

BUY
$1.14 - $2.25 $6,893 - $13,605
6,047 Added 28.94%
26,944 $53,000
Q2 2018

Aug 10, 2018

BUY
$1.59 - $2.38 $33,226 - $49,734
20,897 New
20,897 $40,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.